“The U.S. Centers for Disease Control and Prevention (CDC) recently awarded global consulting and digital services provider ICF (NASDAQ:ICFI) a $31 million recompete contract to provide development, operations and maintenance support to the agency’s nationwide syndromic surveillance platform, BioSense. The contract has a term of four years, including a one-year base and three one-year options.”
“BioSense increases the ability of local, state and national health officials to monitor and respond to the harmful health effects of exposure to disease, addiction and hazardous conditions. It has been at the forefront of the nationwide response to COVID-19, continuously monitoring outbreak patterns and trends and alerting health officials of “hot spots” as they emerge.”
“ICF will work with CDC’s Division of Health Informatics and Surveillance and its partners to improve syndromic surveillance efficacy and coverage, national platform sustainability, partner and community outreach and analytic capabilities.”
“‘ICF has supported BioSense since 2014, playing an integral role in the nation’s most critical public health threat responses, including the Zika and Ebola outbreaks, the opioid epidemic and analyzing the health impacts of heat waves and other natural events,’ said Mark Lee, ICF executive vice president and public sector lead. ‘We have built strong, trusted partnerships with the syndromic surveillance community and public health partners and bring the technical, analytical and public health expertise needed to continue to modernize and optimize this crucial national resource…'” Read the full press release here.
Source: CDC Awards ICF $31 Million Health Surveillance Contract – October 5, 2021. ICF.
ICF was named to the list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come.
